EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Glycerophospholipid and Sphingosine- 1-phosphate Metabolism in Cardiovascular Disease: Mechanisms and Therapeutic Potential

Huiru Tang, Chengxia Kan, Kexin Zhang, Sufang Sheng, Hongyan Qiu, Yujie Ma, Yuqun Wang, Ningning Hou, Jingwen Zhang iD, Xiaodong Sun iD

Journal of Cardiovascular Translational Research · 2025-08 · 18 (4) · 749-761

DOI: 10.1007/s12265-025-10620-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cardiovascular Translational Research, online erschienen am 14.04.2025. Verfasst von Huiru Tang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Clinical Research Center, Shandong Provincial Key Medical and Health Discipline of Endocrinology, Affilia…. Hauptthemen laut MEDLINE: Lysophospholipids, Cardiovascular Diseases, Sphingosine, Glycerophospholipids. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 116 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Taishan Scholar Project of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular disease remains a leading cause of mortality worldwide, driven by factors such as dysregulated lipid metabolism, oxidative stress, and inflammation. Recent studies highlight the critical roles of both glycerophospholipid and sphingosine- 1-phosphate metabolism in the pathogenesis of cardiovascular disorders. However, the contributions of glycerophospholipid-derived metabolites remain underappreciated. Glycerophospholipid metabolism generates bioactive molecules that contribute to endothelial dysfunction, lipid accumulation, and cardiac cell injury while also modulating inflammatory and oxidative stress responses. Meanwhile, sphingosine- 1-phosphate is a bioactive lipid mediator that regulates vascular integrity, inflammation, and cardiac remodeling through its G-protein-coupled receptors. The convergence of these pathways presents novel therapeutic opportunities, where dietary interventions such as omega- 3 polyunsaturated fatty acids and pharmacological targeting of sphingosine- 1-phosphate receptors could synergistically mitigate cardiovascular risk. This review underscores the need for further investigation into the interplay between glycerophospholipid metabolism and sphingosine- 1-phosphate signaling to advance targeted therapies for the prevention and management of cardiovascular disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LysophospholipidsCardiovascular DiseasesSphingosineGlycerophospholipidsCardiovascular SystemHumansAnimalsSignal TransductionSphingosine 1 Phosphate Receptor ModulatorsOxidative Stress

Stichwörter der Autor:innen

AtherosclerosisCardiovascular diseaseGlycerophospholipidsHeart failurePhospholipid metabolism

Substanzen

Lysophospholipidssphingosine 1-phosphateSphingosineGlycerophospholipidsSphingosine 1 Phosphate Receptor Modulators

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Clinical Research Center, Shandong Provincial Key Medical and Health Discipline of Endocrinology, Affiliated Hospital of Shandong Second Medical University, Weifang, China.
  • Department of Endocrinology and Metabolism, Clinical Research Center, Shandong Provincial Key Medical and Health Discipline of Endocrinology, Affiliated Hospital of Shandong Second Medical University, Weifang, China. fy…
  • Department of Endocrinology and Metabolism, Clinical Research Center, Shandong Provincial Key Medical and Health Discipline of Endocrinology, Affiliated Hospital of Shandong Second Medical University, Weifang, China. xi…

ORCID-Profile: Jingwen Zhang, Xiaodong Sun

Förderung

  • National Natural Science Foundation of China
  • Taishan Scholar Project of Shandong Province

Zitieren

APA

Tang, H., Kan, C., Zhang, K., Sheng, S., Qiu, H., Ma, Y., Wang, Y., Hou, N., Zhang, J., & Sun, X. (2025). Glycerophospholipid and Sphingosine- 1-phosphate Metabolism in Cardiovascular Disease: Mechanisms and Therapeutic Potential. Journal of Cardiovascular Translational Research, 18(4), 749-761. https://doi.org/10.1007/s12265-025-10620-3

Vancouver

Tang H, Kan C, Zhang K, Sheng S, Qiu H, Ma Y, et al. Glycerophospholipid and Sphingosine- 1-phosphate Metabolism in Cardiovascular Disease: Mechanisms and Therapeutic Potential. Journal of Cardiovascular Translational Research. 2025;18(4):749-761. doi:10.1007/s12265-025-10620-3

BibTeX
@article{Tang2025,
  author = {Tang, Huiru and Kan, Chengxia and Zhang, Kexin and Sheng, Sufang and Qiu, Hongyan and Ma, Yujie and Wang, Yuqun and Hou, Ningning and Zhang, Jingwen and Sun, Xiaodong},
  title = {Glycerophospholipid and Sphingosine- 1-phosphate Metabolism in Cardiovascular Disease: Mechanisms and Therapeutic Potential},
  journal = {Journal of Cardiovascular Translational Research},
  year = {2025},
  volume = {18},
  number = {4},
  pages = {749--761},
  doi = {10.1007/s12265-025-10620-3}
}
Kostenlos starten →